Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.30 | 0% | ||
CN¥0.30 | 0% | ||
CN¥0.30 | 100% | ||
CN¥0.30 | 100% | ||
CN¥0.15 | 0% | ||
CN¥0.15 | 50% | ||
CN¥0.10 | 42.86% | ||
CN¥0.07 | 16.67% | ||
CN¥0.06 | -14.29% | ||
CN¥0.07 | 0% | ||
CN¥0.07 | 0% | ||
CN¥0.07 | -22.22% | ||
CN¥0.09 | -10% |
Zhejiang Xianju Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 2.87%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XSHE
- Value
- €1.37
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Zhejiang Xianju Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.30. For the next 12 months, Zhejiang Xianju Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.30. This corresponds to a dividend yield of approximately 2.87%.
- The dividend yield of Zhejiang Xianju Pharmaceutical Co Ltd Class A is currently 2.87%.
- Zhejiang Xianju Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in June.
- The next dividend for Zhejiang Xianju Pharmaceutical Co Ltd Class A is expected in June.
- Zhejiang Xianju Pharmaceutical Co Ltd Class A paid dividend every year within the last 10 years.
- Dividends of CN¥0.30 are expected for the next 12 months. This corresponds to a dividend yield of 2.87%.
- Zhejiang Xianju Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Zhejiang Xianju Pharmaceutical Co Ltd Class A was on 18 May 2017 in the ratio 15:10.
- To receive the last dividend of Zhejiang Xianju Pharmaceutical Co Ltd Class A on 5 June 2024 in the amount of CN¥0.30 you had to have the stock in your portfolio before the ex-day on 5 June 2024.
- The last dividend was paid on 5 June 2024.
- In 2022, dividends of CN¥0.15 were paid by Zhejiang Xianju Pharmaceutical Co Ltd Class A.
- Dividends from Zhejiang Xianju Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Zhejiang Xianju Pharmaceutical Co Ltd Class A is located in China.